Molecular handedness and the Nobel award

The Royal Swedish Academy of Sciences awarded the 2026 Nobel Prize in Chemistry to French chemist Henri Kagan and Japanese researcher Kenso Soai on Wednesday, 7 October. The academy honoured the pair for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis. Their research solved a problem surrounding molecular chirality, a property where chemical compounds exist in paired, non-superimposable mirror-image forms, much like left and right hands. In living organisms, biological systems rely almost exclusively on one orientation, incorporating left-handed amino acids into proteins and right-handed sugars into DNA. Standard laboratory reactions typically generate equal fifty-fifty mixtures of both mirror images, making selective synthesis difficult. Kagan and Soai developed methods that compel chemical reactions to yield a specific mirror image.

Breakthroughs in asymmetric synthesis

Kagan demonstrated during the 1980s that chemical reactions could be steered to produce one molecular hand over the other. Years later, Soai developed an autocatalytic reaction, now known as the Soai reaction, that uses the product of the reaction itself as a catalyst to amplify small initial imbalances into an overwhelming excess of a single mirror image. The Nobel committee stated that no one outside biological life had achieved this feat prior to their work. Peter Somfai, a member of the Nobel Committee for Chemistry, described the research during the announcement.

This is probably the coolest experiment in organic chemistry.

The resulting methodologies provided foundational techniques for pharmaceutical development. In therapeutic drugs, different mirror images often interact differently with biological targets. One optical isomer may treat a condition effectively while its counterpart proves inactive or harmful. Rigoberto Hernandez, president of the American Chemical Society, addressed the connection between their chemical discoveries and modern pharmaceuticals.

The medicines we have today would not be possible without this chemistry.

Recognition after a 25-year omission

Kagan, 95, conducted his research at Université Paris-Sud in Orsay, France. Soai, 76, is affiliated with the Tokyo University of Science. French President Emmanuel Macron congratulated Kagan, describing the prize as an immense source of pride for the country and recognition for a lifetime of research. The award arrived twenty-five years after a public dispute over Kagan's exclusion from the 2001 Nobel Prize in Chemistry. That year, the Nobel Foundation awarded the prize to William Knowles, Ryoji Noyori, and Barry Sharpless for work on asymmetric catalysis. The decision led then French research minister Roger-Gérard Schwartzenberg to submit a formal protest letter noting that Kagan had published the discovery of asymmetric catalysis in 1971.

Nobel week ceremonies and prize distribution

The chemistry prize was announced as the third scientific honour of Nobel week, following the medicine and physics awards unveiled on Monday and Tuesday. Soai is the second Japanese scientist in two consecutive years to win the chemistry honour, following Kyoto University professor Susumu Kitagawa, who shared the 2025 award with Richard Robson and Omar Yaghi for developing metal-organic frameworks. The two laureates will share a cash award of 12 million Swedish crowns, worth approximately $1.2 million based on the conversion rate of 10.0309 crowns per dollar. King Carl XVI Gustaf of Sweden will present the medals at an official ceremony in Stockholm on 10 December 2026, the anniversary of Alfred Nobel's death, followed by a banquet at Stockholm City Hall.